COLORADO SPRINGS, Colo., The Spectranetics Corporation today announced U.S. Food and Drug Administration (FDA) Premarket Notification 510(k) submission of the Bridge Occlusion Balloon. Building on the ...
The Spectranetics Corp. said it received clearance of its bridge occlusion balloon for temporary vessel occlusion in cardiac lead extraction procedures. The Colorado Springs, Colorado-based company ...
COLORADO SPRINGS, Colo., Jul 01, 2010 (BUSINESS WIRE) -- Spectranetics Corporation /quotes/comstock/15*!spnc/quotes/nls/spnc (SPNC 5.19, +0.03, +0.58%) today ...
Again, what we saw in LExICon is over 40% of patient are getting extraction for something other than an infection, and that comes into that Class II or the discussion area. So they want to clarify ...
The U.S. FDA’s final guidance for clinical decision support (CDS) systems may be the subject of two citizen’s petitions requesting the agency scrap the guidance ...
Medical device manufacturer Spectranetics Corp. of Colorado Springs is being sold for $2.2 billion to Dutch health electronics giant Royal Philips in the largest deal ever involving a local company.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results